CJ-12954

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCJ-12954
Drug Alias NameCJ-13102CJ-13104CJ-13015CJ-13103CJ-13108 +[7] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter pylori infectionBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infectionBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A